SCHEMBL4764679

SCHEMBL4764679

O=C(O)c1cc2cc(OCCC3CCCCN3)ccc2o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.49
PIM1 P11309 3/20 0.47
AURKB Q96GD4 1/20 0.46
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.44
BLM P54132 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 3/20 0.43
TP53 P04637 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
PIM2 Q9P1W9 1/20 0.41
S1PR1 P21453 1/20 0.41
LTA4H P09960 2/20 0.40
CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768815 0.97 PIM1 (0.48) CHEK2PIM1AURKBMEN1ALDH1A1
SCHEMBL5098984 0.85 PIM1 (0.53) PIM1MEN1ALDH1A1POLBHPGD
SCHEMBL5758402 0.85 MAOB (0.47) CHEK2AURKBMEN1ALDH1A1HPGD
SCHEMBL6447952 0.80 PIM1 (0.50) CHEK2PIM1AURKBMEN1KMT2A
SCHEMBL3866051 0.78 CHEK2 (0.56) CHEK2MEN1KMT2ATP53LTA4H
SCHEMBL18591899 0.78 PIM1 (0.58) PIM1MEN1ALDH1A1POLBHPGD
Hydrochloric Acid SCHEMBL6561583 0.77 CHEK2 (0.55) CHEK2MEN1KMT2ATP53LTA4H
SCHEMBL5104605 0.77 LTA4H (0.52) CHEK2AURKBLTA4H
SCHEMBL6610218 0.77 LTA4H (0.50) CHEK2PIM1PIM2LTA4HCYP1A2
SCHEMBL443699 0.77 MAOB (0.55) PIM1POLBMAOAMAOBLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP disclosed
EP-1158986-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2002-03-27 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO disclosed
EP-1158986-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2001-12-05 EP disclosed
WO-2000038687-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2000-07-06 WO disclosed